Skip to content

LeMaitre Vascular LMAT Return on equity

Return on equity at other companies

ITG
Integer HoldingsITGR
8.6%+3.7pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
9.1%0.0pp
Haemonetics logo
HaemoneticsHAE
19.3%+5.2pp
Abbott logo
AbbottABT
12.4%-18.4pp
Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
4.6%-1.3pp

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Calculated from LeMaitre Vascular’s reported figures.

Based on trailing twelve months.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's return on equity?
LeMaitre Vascular (LMAT) reported return on equity of 16.5% in Q1 2026.
How has LeMaitre Vascular's return on equity changed year-over-year?
LeMaitre Vascular's return on equity increased by 20.2% year-over-year, from 13.8% to 16.5%.
What is the long-term trend for LeMaitre Vascular's return on equity?
Over 5 years (2020 to 2025), LeMaitre Vascular's return on equity has grown at a 3.6% compound annual growth rate (CAGR), from 13.2% to 15.8%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.